A. Shibata

The leucine-rich repeat receptor kinase QSK1 is a novel regulator of PRR-RBOHD complex and is employed by the bacterial effector HopF2Pto to modulate plant immunity

The paper identifies QSK1 as a novel negative regulator of PRR-RBOHD complex and shows it is targeted by the bacterial effector HopF2Pto to suppress plant immunity.

Involvement of the splicing factor SART1 in the BRCA1-dependent homologous recombination repair of DNA double-strand breaks

This study shows SART1 promotes DSB end resection in HR, cooperates with BRCA1 to counteract 53BP1/RIF1, and is required for BRCA1 recruitment to DSBs.

Discovery of an isoflavone oxidative catabolic pathway in legume root microbiota

The paper identifies an oxidative isoflavone catabolic pathway in legume root microbiota, revealing its role in detoxifying isoflavones and shaping microbiota interactions.

Uncovering plant microbiomes using long-read metagenomic sequencing

The paper uses long-read metagenomic sequencing to analyze the rice leaf microbiome, identifying novel bacterial species and genetic elements.

A pair of effectors encoded on a conditionally dispensable chromosome of Fusarium oxysporum suppress host-specific immunity

The paper identifies a pair of effector genes on a CD chromosome in F. oxysporum that suppress Arabidopsis immunity, contributing to host specificity.

Species-specific assembly of root-associated bacterial microbiota mediated by a combination of plant specialized metabolites

The paper shows that tobacco-specific PSMs mediate the enrichment of Arthrobacter in the tobacco endosphere through bacterial catabolism.

Three-dimensional reconstructions of the internal structures of haustoria in parasitic Orobanchaceae

Three-dimensional image reconstruction was used to visualize the spatial organization of cell types in the haustoria of parasitic plants with special reference to their interaction with host roots.

Targeted immuno-antiretroviral HIV therapeutic approach to provide dual protection and boosts cellular immunity: A proof-of-concept study

This study develops a dual-action nanoformulation combining a CCR5 monoclonal antibody and antiretrovirals to enhance HIV protection and immune response, showing improved efficacy compared to individual components.